"Transforming Clinical Care through Cutting Edge Clinical Trials"

During the past decade, PulmonIx, LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PulmonIx, LLC" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "FibroGen" with 3 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Duke University" with 1 trials sponsored and "Exact Sciences Corporation" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PulmonIx, LLC" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Pharm-Olam International" with 1 trials as a collaborator and "Respivant Sciences Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "PulmonIx, LLC" are "Idiopathic Pulmonary Fibrosis" (13 trials), "Chronic Cough" (1 trials), "Cough" (1 trials), "IPF" (1 trials) and "Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease" (1 trials). Many other conditions were trialed in "PulmonIx, LLC" in a lesser frequency.

Most popular intervention types in "PulmonIx, LLC" are "Drug" (14 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Pamrevlumab" (3 trials), "Nintedanib" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials) and "Pirfenidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "PulmonIx, LLC" are 16 trials for "All" genders.

Currently, there are NaN active trials in "PulmonIx, LLC". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in PulmonIx, LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in PulmonIx, LLC, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".